Amelia Technologies

Amelia Technologies LLC is a molecular biotechnology company founded in 2018 that specializes in the development and optimization of molecular diagnostics platforms. The company creates advanced technologies designed to quantify DNA damage in cells and analyze DNA repair processes. Its research and service offerings focus on four primary areas: carcinogenesis, aging-associated diseases, genome editing protocols, and emerging diagnostics platforms. By leveraging these molecular insights, the company seeks to understand how DNA damage impacts human health over time and contributes to age-related conditions.

The company serves a diverse range of clients and collaborators, including academic institutions, industry partners, and government organizations. By providing precise measurements of endpoints associated with DNA maintenance and damage, Amelia Technologies supports research and therapeutic development efforts aimed at addressing complex biological challenges. The firm maintains laboratories in the Washington, D.C. biotechnology corridor and has received federal grant support for its specialized research in biotechnology.